1.77CNY
155.95 MCNY
675.49 MCNY
78.64 M
About BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD.
Sector
CEO
Yu Jing Liu
Headquarters
Beijing
Website
Employees (FY)
1.13 K
Founded
2009
ISIN
CNE100005139
FIGI
BBG00X3X5ZY1
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. engages in the research and development of pharmaceutical products. It mainly focuses on generic and innovative drug research and offers chemical drugs and peptide drugs. The company also provides preclinical and clinical drug development services. Beijing Sun-Novo Pharmaceutical Research was founded on March 9, 2009 and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688621 is 57.50 CNY — it has decreased by 1.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. stocks are traded under the ticker 688621.
688621 stock is 2.81% volatile and has beta coefficient of 0.91. Check out the list of the most volatile stocks — is BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. there?
Yes, you can track BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. financials in yearly and quarterly reports right on TradingView.
688621 stock has fallen by 6.53% compared to the previous week, the month change is a 6.50% fall, over the last year BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. has showed a 19.62% decrease.
688621 net income for the last quarter is 53.08 M CNY, while the quarter before that showed 70.06 M CNY of net income which accounts for −24.23% change. Track more BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. financial stats to get the full picture.
Today BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. has the market capitalization of 6.55 B, it has increased by 3.21% over the last week.
Yes, 688621 dividends are paid annually. The last dividend per share was 0.60 CNY. As of today, Dividend Yield (TTM)% is 0.52%. Tracking BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. dividends might help you take more informed decisions.
BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. dividend yield was 0.42% in 2022, and payout ratio reached 21.99%. The year before the numbers were 0.22% and 20.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 688621 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.13 K employees. See our rating of the largest employees — is BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. stock shows the sell signal. See more of BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.